Literature DB >> 18155507

Echium oil reduces plasma lipids and hepatic lipogenic gene expression in apoB100-only LDL receptor knockout mice.

Ping Zhang1, Elena Boudyguina, Martha D Wilson, Abraham K Gebre, John S Parks.   

Abstract

We tested the hypothesis that dietary supplementation with echium oil (EO), which is enriched in stearidonic acid (SDA; 18:4 n-3), the product of Delta-6 desaturation of 18:3 n-3, will decrease plasma triglyceride (TG) concentrations and result in conversion of SDA to eicosapentaenoic acid (EPA) in the liver. Mildly hypertriglyceridemic mice (apoB100-only LDLrKO) were fed a basal diet containing 10% calories as palm oil (PO) and 0.2% cholesterol for 4 weeks, after which they were randomly assigned to experimental diets consisting of the basal diet plus supplementation of 10% of calories as PO, EO or fish oil (FO) for 8 weeks. The EO and FO experimental diets decreased plasma TG and VLDL lipid concentration, and hepatic TG content compared to PO, and there was a significant correlation between hepatic TG content and plasma TG concentration among diet groups. EO fed mice had plasma and liver lipid EPA enrichment that was greater than PO-fed mice but less than FO-fed mice. Down-regulation of several genes involved in hepatic TG biosynthesis was similar for mice fed EO and FO and significantly lower compared to those fed PO. In conclusion, EO may provide a botanical alternative to FO for reduction of plasma TG concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155507      PMCID: PMC2610363          DOI: 10.1016/j.jnutbio.2007.08.005

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  46 in total

1.  Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype.

Authors:  Syrah Khan; Anne-Marie Minihane; Philippa J Talmud; John W Wright; Margaret C Murphy; Christine M Williams; Bruce A Griffin
Journal:  J Lipid Res       Date:  2002-06       Impact factor: 5.922

2.  A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids.

Authors:  N Yahagi; H Shimano; A H Hasty; M Amemiya-Kudo; H Okazaki; Y Tamura; Y Iizuka; F Shionoiri; K Ohashi; J Osuga; K Harada; T Gotoda; R Nagai; S Ishibashi; N Yamada
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

3.  Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT.

Authors:  J W Furbee; O Francone; J S Parks
Journal:  J Lipid Res       Date:  2001-10       Impact factor: 5.922

4.  Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.

Authors:  J Dallongeville; E Baugé; A Tailleux; J M Peters; F J Gonzalez; J C Fruchart; B Staels
Journal:  J Biol Chem       Date:  2000-10-24       Impact factor: 5.157

Review 5.  Evidence that triglycerides are an independent coronary heart disease risk factor.

Authors:  P Cullen
Journal:  Am J Cardiol       Date:  2000-11-01       Impact factor: 2.778

6.  Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha.

Authors:  Takashi Matsuzaka; Hitoshi Shimano; Naoya Yahagi; Michiyo Amemiya-Kudo; Tomohiro Yoshikawa; Alyssa H Hasty; Yoshiaki Tamura; Jun-ichi Osuga; Hiroaki Okazaki; Yoko Iizuka; Akimitsu Takahashi; Hirohito Sone; Takanari Gotoda; Shun Ishibashi; Nobuhiro Yamada
Journal:  J Lipid Res       Date:  2002-01       Impact factor: 5.922

7.  Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans.

Authors:  R J Pawlosky; J R Hibbeln; J A Novotny; N Salem
Journal:  J Lipid Res       Date:  2001-08       Impact factor: 5.922

8.  Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay.

Authors:  J Xu; M Teran-Garcia; J H Park; M T Nakamura; S D Clarke
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

9.  Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice.

Authors:  Chandna Vasandani; Abdallah I Kafrouni; Antonella Caronna; Yuriy Bashmakov; Michael Gotthardt; Jay D Horton; David K Spady
Journal:  J Lipid Res       Date:  2002-05       Impact factor: 5.922

Review 10.  Distribution, interconversion, and dose response of n-3 fatty acids in humans.

Authors:  Linda M Arterburn; Eileen Bailey Hall; Harry Oken
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

View more
  14 in total

1.  Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.

Authors:  Amanda L Brown; Xuewei Zhu; Shunxing Rong; Swapnil Shewale; Jeongmin Seo; Elena Boudyguina; Abraham K Gebre; Martha A Alexander-Miller; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-19       Impact factor: 8.311

2.  Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver.

Authors:  Swapnil V Shewale; Elena Boudyguina; Xuewei Zhu; Lulu Shen; Patrick M Hutchins; Robert M Barkley; Robert C Murphy; John S Parks
Journal:  J Lipid Res       Date:  2015-04-28       Impact factor: 5.922

3.  Echium oil reduces atherosclerosis in apoB100-only LDLrKO mice.

Authors:  Lolita M Forrest; Elena Boudyguina; Martha D Wilson; John S Parks
Journal:  Atherosclerosis       Date:  2011-10-29       Impact factor: 5.162

4.  In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.

Authors:  Swapnil V Shewale; Amanda L Brown; Xin Bi; Elena Boudyguina; Janet K Sawyer; Martha A Alexander-Miller; John S Parks
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

5.  Dietary echium oil increases long-chain n-3 PUFAs, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome.

Authors:  Katrin Kuhnt; Claudia Fuhrmann; Melanie Köhler; Michael Kiehntopf; Gerhard Jahreis
Journal:  J Nutr       Date:  2014-02-19       Impact factor: 4.798

6.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

7.  Stearidonic and γ-linolenic acids in echium oil improves glucose disposal in insulin resistant monkeys.

Authors:  K Kavanagh; D M Flynn; K A Jenkins; M D Wilson; F H Chilton
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-05-07       Impact factor: 4.006

8.  Fish oil increases atherosclerosis and hepatic steatosis, although decreases serum cholesterol in Wistar rat.

Authors:  Minoo M-Shirazi; Fourugh-Azam Taleban; Ali Reza Abadi; Masoumeh Sabetkasaei
Journal:  J Res Med Sci       Date:  2011-05       Impact factor: 1.852

9.  Echium oil reduces plasma triglycerides by increasing intravascular lipolysis in apoB100-only low density lipoprotein (LDL) receptor knockout mice.

Authors:  Lolita M Forrest; Christopher M Lough; Soonkyu Chung; Elena Y Boudyguina; Abraham K Gebre; Thomas L Smith; Perry L Colvin; John S Parks
Journal:  Nutrients       Date:  2013-07-12       Impact factor: 5.717

10.  Effect of Echium oil compared with marine oils on lipid profile and inhibition of hepatic steatosis in LDLr knockout mice.

Authors:  Patrícia Borges Botelho; Karina da Rocha Mariano; Marcelo Macedo Rogero; Inar Alves de Castro
Journal:  Lipids Health Dis       Date:  2013-03-19       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.